Your browser is not supported

For the best experience, use Google Chrome or Mozilla Firefox.

Xellia Pharmaceuticals

Micro Focus ALM supports digital transformation to deliver life-saving drugs faster by reducing application testing time by 30–40%

Outcomes

30–40% faster application testing
 
Increased team collaboration corrects defects faster
 
Improved overall application quality
 
Full transparency instills confidence in FDA inspections

Related Stories

release-rel-2022-1-2-7091 | Wed Jan 19 20:14:11 PST 2022
7091
release/rel-2022-1-2-7091
Wed Jan 19 20:14:11 PST 2022
Rackspace